Entity family

Browse institutions

Universities, hospitals, research centres, networks, and public bodies. Examples include universities, NHS trusts, research networks.

11,350articles mentioning institutions

22,378institution mentions

9,137distinct institutions extracted

0%of mentions human-reviewed

Filter articles

JournalContent resourceEvidence policyAutomated confidence floorArticles per pageReset filters

“Reviewed + threshold” includes every confirmed correction plus unreviewed proposals at or above the selected model score.

All extracted institutions

Showing 6,361–6,420 of 9,137, ordered by supporting articles. Choose a institution to see its evidence.

New York City1 New York University1 New York University Grossman School of Medicine1 New Zealand Medical Journal1 New centres1 Newcastle Medical School1 Newcastle Mitochondrial cohort1 Newcastle North Tyneside 2 Research Ethics Committee1 Newcastle Upon Tyne Hospitals NHS Trust1 Newcastle upon Tyne National Health Service1 Newcastle-upon-Tyne Foundation Trust1 Newfoundland and Labrador Health Research Ethics Board1 NexImmune1 Next Steps Longitudinal Study1 NextBiomedical Co.1 Ng Teng Fong General Hospital1 Niagara Health1 Nielsen et al1 Nigeria Implementation Science Alliance–Model Innovation and Research Centres1 Nigerian centre1 Nigest Elleni Mohammed Memorial Comprehensive Specialised Hospital1 Nightingale Study1 Ninewells Hospital1 Ninewells Teaching Hospital1 Ningxia Eye Hospital1 Ninth People’s Hospital1 Nippon Medical School1 Nishimoto et al1 Nishizawa et al.1 Nivel Panel Samen Sterk1 Nivel Primary Care Database1 Nobile-Orazio et al1 Noldus Information Technology BV1 Noldus Information Technology BV, NL1 Nor-Work from Norway1 Nordic Biosciences1 Nordic Occupational Cancer Study1 Nordpred Prediction Model1 Norfolk and Norwich Hospital1 North Al-Khuwair Health Center1 North American Hepatitis B Research Network1 North American Neuroendocrine Tumor Society1 North American academic institutions1 North American radiation oncology societies1 North East and Yorkshire Genomic Laboratory Hub1 North London NHS Foundation Trust1 North Tyneside General Hospital1 North Tyneside General Hospital NTGH1 North West Ambulance Service1 North West Genomic Laboratory Hub1 North West Multi-center Research Ethics Committee1 North West School of Emergency Medicine1 North York General Hospital1 Northeast Medical College Hospital1 Northern Finland Birth Cohort Eye Study1 Northern General Hospital1 Northern General Hospitals’ Emergency Departments1 Northern Illinois University1 Northern Ireland Ambulance Service1 Northern Ireland Barrett’s Register1

View all 9,137 institutions on one page

Articles mentioning institutions

11,350 articles · page 314 of 946

655 Theranostic PET defines a ‘goldilocks zone’ for focused ultrasound ablation: balancing tumor disruption and immunotherapeutic antibody delivery

jitc · abstract · 2025-11-04 · 2 matching annotations

96.5%

University of Virginia [89Zr]-αCD47 [89Zr]-aCD47 breast cancer solid tumors NIH DP5OD031846 breast tumors [18F]-Fludeoxyglucose T-FUS

…d regulations of the University of Virginia and approved by the University of Virginia Animal Care and Use Committee.References Demir ZEF, Sheybani ND…

656 Focused ultrasound thermal ablation and CD40 agonist drive tumor regression and immunologic memory via innate and adaptive reprogramming in breast cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

94.1%

University of Virginia cancer breast cancer BC NIH DP5OD031846 αCD40 T-FUS

…d regulations of the University of Virginia and approved by the University of Virginia Animal Care and Use Committee.Abstract 656 Figure 1Subtotal T-F…

658 KAN-001, a defined live biotherapeutic product (LBP) for NSCLC, enhances ICI response in preclinical models and demonstrates manufacturing consistency and strain-resolved viability

jitc · abstract · 2025-11-04 · 2 matching annotations

96.5%

MD Anderson Cancer Center CRCHUM KAN-001 non-small cell lung cancer NSCLC anti-PD-1 therapy Canadian Council PD-1 therapy

…Acknowledgements We thank Nadim Ajami and Jennifer Wargo of the MD Anderson Cancer Center for their continued support of the KAN-001 program.Ethics Appro…

665 TROP2 remodeling of the immune microenvironment in triple negative breast cancer

jitc · abstract · 2025-11-04 · 2 matching annotations

92.9%

Massachusetts General Hospital MGH Histopathology Research Core TNBC Immunomedics/Gilead Sacituzumab govitecan triple-negative breast cancer human breast cancer immunotherapy chemotherapy

… approved by the Institutional Animal Care and Use Committee at Massachusetts General Hospital (Protocol #:2004N000228).…

668 Fatty acid metabolism promotes innate immune evasion and resistance to immunotherapy in irradiated glioblastoma

jitc · abstract · 2025-11-04 · 2 matching annotations

82.9%

TCGA glioblastoma FASNi anti-PD-1 IACUC #2019-0042

…ere abrogated by deletion of cGAS, RIG-I, or MDA5. Importantly, TCGA pan-cancer analysis revealed that FASN expression inversely cor…

670 Proton radiotherapy alone versus combined with immunotherapies or tyrosine kinase inhibitors for barcelona clinic liver cancer stage B or C hepatocellular carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

93.9%

Linkou Chang Gung Memorial Hospital Chang Gung Medical Foundation lenvatinib sorafenib atezolizumab-bevacizumab pembrolizumab Proton radiotherapy hepatocellular carcinoma HCC Proton-TKI

…cer (BCLC) stage B or C HCC treated with proton radiotherapy at Linkou Chang Gung Memorial Hospital between 2020 and 2023. Patients were stratified into three grou…

679 Combined radiation and adoptive CTL therapy in advanced extramammary paget disease with pulmonary and nodal metastases: a case report and rationale for case series expansion

jitc · abstract · 2025-11-04 · 2 matching annotations

87.0%

Radiother Oncol Proc Natl Acad Sci USA melanoma-specific Extramammary Paget’s disease (EMPD)IL-2 EMPD melanoma solid tumors Adoptive CTL therapy EBV-related cancers+1 more

…fter progression on immunotherapy: Results of a phase II trial. Radiother Oncol. 2021 Sep;162:60-67. doi: 10.1016/j.radonc.2021.06.037. Epub 20…

680 Assessing outcomes in melanoma patients with brain metastases: a retrospective study of immunotherapy, radiation, and surgical treatment sequencing

jitc · abstract · 2025-11-04 · 2 matching annotations

94.8%

Brown University Health Lifespan- Rhode Island Hospital Institutional Review Board melanoma ipilimumab nivolumab Brain metastases advanced melanoma surgery ICI

…ort study of melanoma patients with brain metastases treated at Brown University Health between 2005 to 2024. Patients were categorized based on the se…

690 Boosting treatment outcomes for high-grade serous ovarian cancer via the integration of antibody-drug conjugates and immune system stimulants

jitc · abstract · 2025-11-04 · 2 matching annotations

95.6%

Imperial College London University of Alabama at Birmingham Trastuzumab emtansine trastuzumab High-grade serous ovarian carcinoma (HGSOC)CBD-IL-7 epithelial ovarian cancer T-DM1PMPC CBD-IL-12 T-DM1

…edgements CBD-IL-7 and CBD-IL-12 generated by Dr. Jun Ishihara, Imperial College London.Ethics Approval This study was approved by the Institutional An…

692 Targeting ICOS receptor to improve breast cancer immunotherapy

jitc · abstract · 2025-11-04 · 2 matching annotations

80.4%

Austin Health Animal Ethics Committee Victorian Cancer Agency breast cancer lung cancer melanoma NBCF

…al Animal Studies - Animal-related studies were approved by the Austin Health Animal Ethics Committee - Application number A2021_05727. Human Sample Collection - Hum…

702 Pulsed electrical field ablation plus intratumoral immunotherapy for head and neck squamous cell carcinoma

jitc · abstract · 2025-11-04 · 2 matching annotations

78.7%

Int J Mol Sci squamous cell carcinoma HNSCC intra-tumoral immunotherapy injection pulsed electrical field ablation hepatocellular carcinoma

…ting prognosis and therapy outcome of hepatocellular carcinoma. Int J Mol Sci. Feb 08 2023;24(4).Jardim DL, Goodman A, de Melo Gagliato D, Ku…

734 Tertiary lymphoid structures as hallmarks of response to neoadjuvant chemoimmunotherapy in locally advanced non-small cell lung cancer NADIM trial

jitc · abstract · 2025-11-04 · 2 matching annotations

95.2%

Hospital Puerta de Hierro nivolumab NSCLC Resectable Lung Cancer

…tocol was approved by the clinical research ethics committee of Hospital Puerta de Hierro (ref. 20.16) and the Spanish Lung Cancer Group (SLCG) Board (re…